IBX.AX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 00:50):

Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy...

Stats
Today's Volume	13 188.00
Average Volume	72 143.00
Market Cap	2.42M
EPS	$0 ( 2024-02-28 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.170
ATR14	$0 (0.00%)

Imagion Biosystems Ltd Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Imagion Biosystems Ltd Financials

Annual	2023
Revenue:	$1.65M
Gross Profit:	$1.65M (100.00 %)
EPS:	$-0.400

Q4	2023
Revenue:	$955 235
Gross Profit:	$955 235 (100.00 %)
EPS:	$-0.390

Q2	2023
Revenue:	$690 012
Gross Profit:	$-414 144 (-60.02 %)
EPS:	$-0.270

Q1	2023
Revenue:	$345 006
Gross Profit:	$-759 150 (-220.04 %)
EPS:	$-0.00340

Financial Reports:

No articles found.

Imagion Biosystems Ltd

Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to detect cancer. Imagion Biosystems Limited has a collaborative research program with Patrys Limited to use the combined technologies for enhancing brain tumor imaging and diagnosis; and a joint development agreement with Global Cancer Technology, Inc. to develop GCT's novel nanoscintillator technology for the treatment of breast cancer. The company was incorporated in 2016 and is based in San Diego, California.